Cochrane Review Group
Tobacco Addiction
68 systematic reviews in Tobacco Addiction ask 430 questions. 6% have no studies to answer them, 27% rest on very low certainty evidence and 27.2% reach moderate or high certainty.
Reviews
68
Questions
430
current versions
No studies
6%
Moderate or high
27.2%
No studies 26 · 6%Ungraded 12 · 2.8%Very low 116 · 27%Low 159 · 37%Moderate 87 · 20.2%High 30 · 7%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Smoking cessation counselling vs no smoking cessation counselling, grouped by intensity of intervention Quit at longest · individuals who smoke cigarettes and are admitted to a hospital for medical or surgical care Interventions for smoking cessation in hospitalised patients (2024) · Cochrane | RR 1.52 [0.8, 2.89] | 2 studies · 1417 participants | Very low |
Telephone quitline referral vs no treatment or usual care Quitline referral vs control · smoking cessation in hospitalised patients Interventions for smoking cessation in hospitalised patients (2024) · Cochrane | RR 1.17 [0.7, 1.96] | 2 studies · 1870 participants | Very low |
Telephone quitline referral vs no treatment or usual care Health system telephone counselling vs quitline · smoking cessation in hospitalised patients Interventions for smoking cessation in hospitalised patients (2024) · Cochrane | RR 1.23 [1, 1.51] | 3 studies · 3260 participants | Very low |
Smoking cessation counselling vs no smoking cessation counselling, grouped by intensity of intervention Quit at longest · individuals who smoke cigarettes and are admitted to a hospital for medical or surgical care Interventions for smoking cessation in hospitalised patients (2024) · Cochrane | RR 1.04 [0.9, 1.2] | 7 studies · 4627 participants | Very low |
Hospital‐only intervention vs intervention that continues after hospital discharge Behavioural support ‐ asynchronous** · smoking cessation in hospitalised patients Interventions for smoking cessation in hospitalised patients (2024) · Cochrane | RR 0.97 [0.83, 1.14] | 2 studies · 1598 participants | Very low |
Nicotine EC vs behavioural support only/no support Serious adverse events at 4 weeks to 8 months Assessed via self‐report and medical records · People who smoke Electronic cigarettes for smoking cessation (2024) · Cochrane | RR 0.89 [0.59, 1.34] | 10 studies · 3263 participants | Very low |
Intervention NR Bupropion therapy plus behavioral intervention vs behavioral intervention alone (continuous waterpipe smoking abstinence, defined as an expired CO of 9 ppm or less at the 6‐month postintervention · people who use waterpipe Interventions for waterpipe smoking cessation (2023) · Cochrane | RR 0.77 [0.42, 1.41] | 121 participants | Very low |
Intervention NR Bupropion therapy plus behavioral support versus self‐help (continuous waterpipe smoking abstinence, defined as an expired CO of 9 ppm or less at the 6‐month postintervention · people who use waterpipe Interventions for waterpipe smoking cessation (2023) · Cochrane | RR 1.94 [0.94, 4] | 86 participants | Very low |
Intervention NR E‐health interventions · people who use waterpipe Interventions for waterpipe smoking cessation (2023) · Cochrane | OR 1.48 | 2 studies · 389 participants | Very low |
Cytisine vs varenicline Neuropsychiatric SAEs · people who smoke tobacco Nicotine receptor partial agonists for smoking cessation (2023) · Cochrane | no estimate extracted | NR | No studies |
Cytisine vs varenicline Cardiac SAEs · people who smoke tobacco Nicotine receptor partial agonists for smoking cessation (2023) · Cochrane | no estimate extracted | NR | No studies |
Cytisine vs nicotine replacement therapy SAEs · people who smoke tobacco Nicotine receptor partial agonists for smoking cessation (2023) · Cochrane | RR 1.15 [0.76, 1.75] | 1 study · 1310 participants | Very low |
Reviews 68
Biomedical risk assessment as an aid for smoking cessation
CochraneSoF table
3 questions
Mobile phone text messaging and app‐based interventions for smoking cessation
CochraneSoF table
3 questions
Motivational interviewing for smoking cessation
CochraneSoF table
4 questions
Interventions to increase adherence to medications for tobacco dependence
CochraneSoF table
3 questions
Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation
CochraneSoF table
1 questions
Real‐time video counselling for smoking cessation
CochraneSoF table
1 questions
Smoking cessation intervention for reducing disease activity in chronic autoimmune inflammatory joint diseases
CochraneSoF table
1 questions
Smoking reduction interventions for smoking cessation
CochraneSoF table
8 questions
Competitions for smoking cessation
CochraneSoF table
2 questions
Nicotine replacement therapy versus control for smoking cessation
CochraneSoF table
1 questions
Family and carer smoking control programmes for reducing children's exposure to environmental tobacco smoke
CochraneSoF table
14 questions
Enhancing partner support to improve smoking cessation
CochraneSoF table
2 questions
Oral and sublingual immunotherapy for egg allergy
CochraneSoF table
4 questions
Mass media interventions for preventing smoking in young people
CochraneSoF table
1 questions
Group behaviour therapy programmes for smoking cessation
CochraneSoF table
6 questions
Nursing interventions for smoking cessation
CochraneSoF table
3 questions
Individual behavioural counselling for smoking cessation
CochraneSoF table
3 questions
Tobacco cessation interventions for young people
CochraneSoF table
13 questions
Healthcare financing systems for increasing the use of tobacco dependence treatment
CochraneSoF table
2 questions
Mass media interventions for smoking cessation in adults
CochraneSoF table
4 questions
Internet‐based interventions for smoking cessation
CochraneSoF table
7 questions
Incentives for preventing smoking in children and adolescents
CochraneSoF table
2 questions
System change interventions for smoking cessation
CochraneSoF table
7 questions
Tobacco packaging design for reducing tobacco use
CochraneSoF table
6 questions
Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers
CochraneSoF table
38 questions